Macroscopy
Clinical Pharmacology & Therapeutics (2009); 86, 1, 12–14 doi:10.1038/clpt.2009.33
Chutes and Ladders on the Critical Path:Comparative Effectiveness, Product Value, and the Use of Biomarkers in Drug Development
J Woodcock1
1Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA
Correspondence: J Woodcock, (janet.woodcock@fda.hhs.gov)
